Once-a-day Immunosuppression(CISECON_a_day)

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Chronic Renal Disease
Interventions
DRUG

advagrf

"All enrolled subjects will discontinue the existing Tacrolimus preparations for 6 months from enrollment and be converted to Extended Release Tacrolimus at a biologically equivalent dose. They will also discontinue enteric-coated mycophenolate sdium or mycophenolate sodium and be treated with Sirolimus and observed.~advagrf+sirolimus one time to eat."

Trial Locations (7)

Unknown

Nephrology, Pusan National University Hospital, Busan

Bundang CHA Medical Center,, Gyeonggi-do

Inje University Ilsan Paik Hospital, Gyeonggido

Korea University Medical Center, Seoul

Severance Hospital, Seoul

Soonchunhyang University Hosptial, Seoul

Dept. of Surgery, Ulsan University Hospital, Ulsan

All Listed Sponsors
lead

Ajou University School of Medicine

OTHER

NCT01964014 - Once-a-day Immunosuppression(CISECON_a_day) | Biotech Hunter | Biotech Hunter